Daniel J. Anderson
Estonian Information Technology College(EE)Queen Elizabeth University Hospital(GB)Monash University(AU)
Publications by Year
Research Areas
Ubiquitin and proteasome pathways, Endoplasmic Reticulum Stress and Disease, Crystallization and Solubility Studies, X-ray Diffraction in Crystallography, Computational Drug Discovery Methods
Most-Cited Works
- → RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth(2010)1,616 cited
- → Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7(2011)808 cited
- → Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity(2012)623 cited
- → Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)(2015)427 cited
- → Targeting the AAA ATPase p97 as an Approach to Treat Cancer through Disruption of Protein Homeostasis(2015)393 cited
- → Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death(2013)381 cited